sumatriptan oral film (KL-00119) / Klaria, CNX Therapeutics - LARVOL DELTA

Klaria submits Marketing Authorization Application for Sumatriptan Alginate Film in Europe (Market Screener) - "Klaria Pharma AB...announces that the Company has submitted a Marketing Authorization Application (MAA) for Sumatriptan Alginate Film for the treatment of Migraine in the European Union. Pending positive validation, Sumatriptan Alginate Film will be subject to a regulatory assessment according to the standard timeline, which would result in approval in Q1, 2024....The MAA has been submitted to the medical regulatory body in Germany (BfArM) in a decentralized procedure. BfArM is the national competent authority responsible for the authorization of Sumatriptan Alginate Film in the European Union. The MAA has also been submitted to the regulatory authorities in Spain and Italy."

European regulatory • CNS Disorders • Migraine • Pain

"Klaria submits Marketing Authorization Application for Sumatriptan Alginate Film in Europe https://t.co/v2UPdgMpbN" (@CisionNews)

European regulatory

Patent for Klaria’s Sumatriptan Alginate Film Granted in Russia (Cision) - "Klaria’s patent for Sumatriptan Alginate Film has been granted in Russia. This grant extends the global patent protection for Klaria’s most advanced development program. The period of patent protected exclusivity in the Russian Federation will last until 2037....The granted Sumatriptan Alginate Film patent protects the combination of the active substance, Sumatriptan, with the Alginate Film. This granting of the Sumatriptan Alginate Film patent is the third granting of this patent world-wide, with the patent having been granted in the United States in 2021 and in Mexico in January, 2022."

Patent • CNS Disorders • Migraine • Pain

"Patent for Klaria’s Sumatriptan Alginate Film Granted in Russia https://t.co/txdBTi4Ekq" (@CisionNews)

"Patent för Klarias Sumatriptan Alginatfilm beviljas i Ryssland https://t.co/blUlleV7iD" (@CisionNews)

"Patent för Klarias Sumatriptan Alginat Film att beviljas i Mexiko https://t.co/8x7acQdx1o" (@CisionNews)